Rushad Patel
Attending hematologist at Beth Israel Deaconess Medical Center and Assistant Professor of Medicine at Harvard Medical School, specializing in thrombosis and cancer-associated thrombosis.
1
APPEARANCES
1
PODCASTS
Sep 17, 2026
3:46
Ruched, I'm curious, what is currently known about GPL1 RAs and the risk of VTE specifically?
Rushad PatelGUEST
It's limited because dedicated studies, especially like prospective VTE has not been an outcome so far, but there are some works that's pointing in the direction.
Rushad PatelGUEST
Like why would we be interested in that question? I think it stems back to the fact that obesity is a very well-known and well-recognized risk factor for venous thromboembolism.
Rushad PatelGUEST
Diabetes is a less well-known, but also recognized, especially when it's uncontrolled, likely related to sort of inflammation and metabolic disturbances for VTE.
Rushad PatelGUEST
And so a drug that affects these two risk factors might have an impact on venous thromboembolism.
16 MINS LATER